Skip to Content

BIMERVAX emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)

Licence status
Authorised: 30/03/2023
Active substances
SARS-CoV-2 virus, variants B.1.351-B.1.1.7, spike protein, receptor binding domain fusion heterodimer
Dosage Form
Emulsion for injection
Licence number
EU/1/22/1709/001-004
Licence holder
Hipra Human Health S.L.

Licence information

ATC code
J07BN01 covid-19, RNA-based vaccine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
30/03/2023